MedTrace Logo

Acquisition of Portal Venous CTCs and Exosomes From Patients With Pancreatic Cancer by EUS

NCT03821909 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2019-01-31

No results posted yet for this study

Summary

The investigators are going to explore the diagnostic and prognostic value of circulating tumor cells and exosomes extracted from the portal venous blood obtained with endoscopic ultrasound in pancreatic cancer patients.

Conditions

Interventions

PROCEDURE

Endoscopic ultrasound-guided protal venous blood sampling

We wil obtain portal venous blood samples via endoscopic ultrasound(EUS) in patients with suspected pancreatic masses.

Sponsors & Collaborators

  • Ying Lv

    lead OTHER

Principal Investigators

  • Ying Lv, PhD · The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-08-01
Primary Completion
2020-08-31
Completion
2020-09-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03821909 on ClinicalTrials.gov